Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Submitted by
admin
on October 21, 2011 - 10:11am
Source:
Seeking Alpha
News Tags:
Keryx
FDA
Aeterna Zentaris
colorectal cancer
Perifosine Akt inhibitor
Headline:
Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Do Not Allow Advertisers to Use My Personal information
